RT Journal Article
SR Electronic
T1 Ventricular Arrhythmias, Part III: Benefits And Risks Of Antiarrhythmic Therapy
JF The Journal of the American Board of Family
                Practice
JO J Am Board Fam Med
FD American Board of Family Medicine
SP 255
OP 266
DO 10.3122/jabfm.1.4.255
VO 1
IS 4
A1 Grauer, Ken
A1 Gums, John
YR 1988
UL http://www.jabfm.org/content/1/4/255.abstract
AB In Parts I and II of this series, clinical significance, prevalence, and special concerns in the evaluation of patients with ventricular arrhythmias were reviewed. We now examine the categories of antiarrhythmic drugs and offer indications for their use. Reasons why a patient may not respond to antiarrhythmic therapy, end points of therapy, and the benefits and drawbacks of measuring serum drug levels are addressed. Use of newer drugs and additional treatment modalities are discussed in the final installment.